Booster shot study for COVID-19 in adults
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This Phase 3 trial tests a booster vaccine made from a three-part COVID-19 protein (aimed at XBB, BA.5, and Delta) to see how well it works and is tolerated. It may help adults who are due for a COVID-19 booster, including people with certain health conditions, depending on screening results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older (including people with underlying health problems).
- Got a COVID-19 vaccine at least 6 months ago, or are getting boosted now.
- Either had COVID-19 at least 3 months ago or have never had COVID-19.
- Be able to understand the study, agree freely, and follow study visits and instructions.
- Start by passing screening blood/immune tests and having no recent positive COVID tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a booster vaccine made from a COVID-19 protein (XBB + prototype) to help your immune system respond better. You may be able to join if you’re an adult who is due for a booster and meets health and safety screening checks.
This trial tests a new type of COVID-19 booster vaccine that targets a protein to help your immune system. It's for people who already had a primary vaccine series and at least one mRNA booster, with the last booster at least 6 months ago.
This study looks at how well a COVID-19 booster works in adults who need long-term medicines that lower immune response. It aims to see whether immunosuppressed people benefit from booster vaccination safely.
This study tests whether it is safe and effective to give an Ebola vaccine at the same time as a COVID-19 booster shot. It may help find a way to protect against both diseases with fewer clinic visits.
This trial tests a nasal spray booster for people who have already had 2-3 doses of COVID-19 inactivated vaccine. It studies if the spray is safe and boosts your immune system. You can join if you are healthy, have not had COVID-19 in the last 3 months, and had your last vaccine dose more than 6 months ago.
This trial tests a new nasal spray booster for COVID-19 in adults 18–64 who have already had a primary vaccine series and at least one booster. The goal is to see if it is safe and triggers a good immune response.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.